NCT05842018 2023-05-03Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)Tianjin Medical University Cancer Institute and HospitalPhase 2 Unknown30 enrolled